Binge eating disorder, obesity, and tobacco smoking

Journal of Addiction Medicine

Volumn 4, Issue 1, 2010, Pages 11-19

  White, Marney A ^a   Grilo, Carlos M ^a   O'Malley, Stephanie S ^a   Potenza, Marc N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binge eating disorder; Cognitive behavior therapy; Comorbidity; Nicotine dependence; Obesity; Substance use disorders

Indexed keywords

EID: 77954392900     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3181ce38c8     Document Type: Conference Paper

References (73)

1. Fairburn CG, Cooper Z. The eating disorder examination. In: Fairburn CG, Wilson GT, eds. Binge Eating: Nature, Assessment, and Treatment. 12th ed. New York: Guilford Press; 1993:317-360.
2. Grilo CM, Masheb RM, Lozano-Blanco C, et al. Reliability of the Eating Disorder Examination in patients with binge eating disorder. Int J Eat Disord. 2004;35:80-85. (Pubitemid 38040785)
3. Grilo CM, Masheb RM, Wilson GT. A comparison of different methods for assessing the features of eating disorders in patients with binge eating disorder. J Consult Clin Psychol. 2001;69:317-322. (Pubitemid 32488290)
4. Wilson GT, Grilo CM, Vitousek K. Psychological treatments for eating disorders. Am Psychol. 2007;62:199-216.
5. National Institute for Clinical Excellence (2004). Eating Disorders-Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa, and related Eating Disorders (Clinical Guideline No. 9). London: National Institute for Clinical Excellence. Available at: www.nice.org.uk/ guidance/CG9.
6. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition. Washington, DC: American Psychiatric Association.
7. Grilo CM, Hrabosky JI, White MA, et al. Overvaluation of shape and weight in binge eating disorder and overweight controls: Refinement of a diagnostic construct. J Abnorm Psychol. 2008;117:414-419.
8. Grilo CM, Crosby RD, Masheb RM, et al. Overvaluation of shape and weight in binge eating disorder, bulimia nervosa, and subthreshold bulimia nervosa. Behav Res Ther. 2009;47:692-696.
9. Grilo CM, Masheb RM, White MA. Significance of overvaluation of shape/weight in binge eating disorder: Comparative study with overweight and bulimia nervosa. Obesity. 2009 Aug 27. [Epub ahead of print] PMID: 19713949.
10. Striegel-Moore RH, Franko DL. Should binge eating disorder be included in the DSM-V? A critical review of the state of the evidence. Annu Rev Clin Psychol. 2008;4:305-324.
11. Hudson JI, Hiripi E, Pope HG, et al. The prevalence and correlates of eating disorders in the NCS replication. Biol Psychiatry. 2007;61:348-358.
12. Grilo CM, Lozano C, Masheb RM. Ethnicity and sampling bias in binge eating disorder: Black women who seek treatment have different characteristics than those who do not. Int J Eat Disord. 2005;38:257-262. (Pubitemid 41618966)
13. Grilo CM. What treatment research is needed for eating disorder not otherwise specified and binge eating disorder? In: Grilo CG, Mitchell JE, eds, The Treatment of Eating Disorders: A Clinical Handbook. New York: Guilford Press; 2010:554-568.
14. Reas DL, Grilo CM. Timing and sequence of the onset of overweight, dieting, and binge eating in overweight patients with binge eating disorder. Int J Eat Disord. 2007;40:165-170.
15. Roehrig M, Masheb RM, White MA, et al. Dieting frequency in obese patients with binge eating disorder: Behavioral and metabolic correlates. Obesity. 2009;17:689-697.
16. Puhl RM, Heuer CA. The stigma of obesity: A review and update. Obesity. 2009;17:941-964.
17. Pike KM, Dohm FA, Striegel-Moore RH, et al. A comparison of black and white women with binge eating disorder. Am J Psychiatry. 2001; 158:1455-1460. (Pubitemid 32847245)
18. Masheb RM, Grilo CM. Prognostic significance of two sub-categorization methods for the treatment of binge eating disorder: Negative affect and overvaluation predict, but do not moderate, specific outcomes. Behav Res Ther. 2008;46:428-437.
19. Grilo CM, White MA, Masheb RM. DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder. Int J Eat Disord. 2009;42:228-234.
20. Masheb RM, Grilo CM. Examination of predictors and moderators for self-help treatments of binge eating disorder. J Consult Clin Psychol. 2008;76:900-904.
21. White MA, Grilo CM. Psychiatric comorbidity in binge eating disorder as a function of smoking history. J Clin Psychiatry. 2006;67:594-599. (Pubitemid 43764236)
22. White MA, Grilo CM. Symptom severity in obese women with binge eating disorder as a function of smoking history. Int J Eat Disord. 2007;40:77-81.
23. White MA, Masheb RM, Grilo CM. Self-reported weight gain following smoking cessation: A function of binge eating behaviour. Int J Eat Disorders. 2009 Aug 28. [Epub ahead of print] PMID: 19718662.
24. Allison KC, Grilo CM, Masheb RM, et al. Binge eating disorder and night eating syndrome: A comparative study of disordered eating. J Consult Clin Psychol. 2005;73:1107-1115.
25. Masheb RM, Grilo CM. Eating patterns and breakfast consumption in obese patients with binge eating disorder. Behav Res Ther. 2006;44: 1545-1553. (Pubitemid 44442144)
26. Grilo CM, Masheb RM. A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder. Behav Res Ther. 2005;43:1509-1525. (Pubitemid 41282796)
27. Wilson GT, Wilfley DE, Agras WS, Bryson SW. Psychological treatments of binge eating disorder. Arch Gen Psychiatry. 2010; 67:94-101.
28. Ricca V, Mannucci E, Mezzani B, et al. Fluoxetine and fluvoxamine combined with individual cognitive-behavioral therapy in binge eating disorder: A one-year follow-up study. Psychother Psychosom. 2001;70: 298-306. (Pubitemid 34701802)
29. Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison. Biol Psychiatry. 2005;57:301-309. (Pubitemid 40187375)
30. Reas DL, Grilo CM. Review and meta-analysis of pharmacotherapy for binge eating disorder. Obesity. 2008;16:2024-2038.
31. Grilo CM, Masheb RM, Salant SL. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial. Biol Psychiatry. 2005;57:1193-1201. (Pubitemid 40615782)
32. Claudino AM, de Oliveira IR, Appolinario JC, et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge eating disorder. J Clin Psychiatry. 2007;68:1324-1332. (Pubitemid 47524510)
33. Grilo CM, Masheb RM, Wilson GT. Rapid response to treatment for binge eating disorder. J Consult Clin Psychol. 2006;74:602-613. (Pubitemid 44128239)
34. Masheb RM, Grilo CM. Rapid response predicts treatment outcomes in binge eating disorder: Implications for stepped care. J Consult Clin Psychol. 2007;75:639-644.
35. O'Malley SS, Sinha R, Grilo CM, et al. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol dependent women: A randomized, double-blind, placebo controlled trial. Alcohol Clin Exp Res. 2007;31:625-634. (Pubitemid 46434899)
36. Spring B, Howe D, Berendsen M, et al. Behavioral intervention to promote smoking cessation and prevent weight gain: A systematic review and meta-analysis. Addiction. 2009;104:1472-1486.
37. Perkins KA, Marcus MD, Levine MD, et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol. 2001;69:604-613.
38. Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101(Suppl 1):152-160.
39. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction 2006;101(Suppl 1):142-151.
40. Grant JE, Brewer JA, Potenza MN. Neurobiology of substance and behavioral addictions. CNS Spectr. 2006;11:924-930.
41. Holden C. 'Behavioral' addictions: Do they exist? Science. 2001;294: 980-982.
42. O'Brien CP, Volkow N, Li TK. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry. 2006;163:764-765. (Pubitemid 44464516)
43. Shaffer HJ. Strange bedfellows: A critical view of pathological gambling and addiction. Addiction. 1999;94:1445-1448.
44. Volkow ND, O'Brien CP. Issues for DSM-V: Should obesity be included as a brain disorder? Am J Psychiatry. 2007;164:708-710.
45. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555-560. (Pubitemid 40594193)
46. Gearhardt AN, Corbin WR, Brownell KD. Food addiction: An examination of the diagnostic criteria for dependence. J Addict Med. 2009;3:1-7.
47. Gold MS, Graham NA, Cocores JA, et al. Food addiction? J Addict Med. 2009;3:42-45.
48. Brownell KD. Fast food and obesity in children. Pediatrics. 2004;113: 132.
49. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: A HuGE review. Am J Epidemiol. 2005;162:101-114. (Pubitemid 41373535)
50. Von Deneen KM, Gold MS, Liu Y. Food addiction and cues in Prader-Willi syndrome. J Addict Med. 2009;3:19-26.
51. Abizaid A, Gao Q, Horvath TL. Thoughts for food: Brain mechanisms and peripheral energy balance. Neuron. 2006;51:691-702. (Pubitemid 44374909)
52. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am J Psychiatry. 2003;160:1041-1052.
53. Everitt B, Robbins TW. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci. 2005;8: 1481-1489. (Pubitemid 41573659)
54. Hoebel BG, Avena NM, Bocarsly ME, et al. Natural addiction: A behavioral and circuit model based on sugar addiction in rats. J Addict Med. 2009;3:33-41.
55. Wang G-J, Volkow ND, Thanos P, et al. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: A concept review. J Addict Dis. 2004;23:39-53. (Pubitemid 39045340)
56. Wang GJ, Volkow ND, Thanos PK, et al. Imaging of brain dopamine pathways: Implications for understanding obesity. J Addict Med. 2009; 3:8-18.
57. Brewer JA, Grant JE, Potenza MN. The treatment of pathologic gambling. Addict Disord Treat. 2008;7:1-14.
58. Grant JE, Kim SW, Hollander E, et al. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology. 2008;200:521-527.
59. Tamminga CA, Nestler EJ. Pathological gambling: Focusing on the addiction, not the activity. Am J Psychiatry. 2006;163:180-181.
60. Souza GA, Ebaid GX, Seiva FR, et al. N-Acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects. Evid Based Complement Alternat Med 2008 Nov 11. [Epub ahead of print] PMID: 19001480.
61. Knackstedt LA, LaRowe S, Mardikian P, et al. The role of cystineglutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009;65:841-845.
62. Grant JE, Kim SW, Odlaug BL. N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biol Psychiatry. 2007;62:652-657.
63. LaRowe SD, Mardikian P, Malcolm R, et al. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006; 15:105-110. (Pubitemid 43207196)
64. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: Results of two national surveys. Am J Psychiatry. 2006;163: 297-302.
65. Potenza MN, Steinberg MA, Wu R. Characteristics of gambling helpline callers with self-reported gambling and alcohol use problems. J Gambl Stud. 2005;21:233-254. (Pubitemid 41216442)
66. Kalivas PW, Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry. 1989;25:913-928. (Pubitemid 19122767)
67. Piazza PV, Le Moal M. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopa-minergic neurons. Annu Rev Pharmacol Toxicol. 1996;36:359-378. (Pubitemid 26168703)
68. Blanco C, Potenza MN, Kim SW, et al. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009;167:161-168.
69. Merlo LJ, Klingman C, Malasanos TH, et al. Exploration of food addiction in pediatric patients: A preliminary investigation. J Addict Med. 2009;3:26-32.
70. Brownell KD, Farley T, Willett WC, et al. The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med. 2009;361:1599-1605.
71. Surgeon General. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. United States Department of Health and Human Services. Available at: http://www.surgeongeneral. gov/topics/obesity/ calltoaction/fact-glance.htm. Accessed 22 November, 2006.
72. Uhl GR, Grow RW. The burden of complex genetics in brain disorders. Arch Gen Psychiatry. 2004;61:223-229.
73. Potenza MN, Taylor JR. Found in translation: Understanding impulsiv-ity and related constructs through integrative preclinical and clinical research. Biol Psychiatry. 2009;66:714-716.